Paul Tudor Jones Dismisses Chances of Fed Rate Cuts Under Potential Chair Warsh Hajj 2026 Over 15 Million Foreign Pilgrims Arrive in Saudi Arabia Amid Regional Tensions Nvidia Navigates Dual Regulatory Hurdles as 200 Billion CPU Market Forecast Includes China WSJ Heard on the Street Launches Eighth Annual StockPicking Contest Energy Transfer EBITDA Outlook Strengthens Analyst Lifts Price Target NASA Selects Blue Origin for First Lunar Mission in 20 Billion Moon Base Plan RWAYI Q1 2026 Earnings Net Investment Income Misses Estimates on Lower Yields HTO Q1 2026 Earnings EPS Surpasses Estimates with 533 Beat IMVT Q1 2026 Earnings WiderThanExpected Loss as Clinical Development Advances Amrize Ltd Ordinary Shares AMRZ Q1 2026 Earnings EPS Misses Estimates Amid Significant Surprise FTAI Q1 2026 Earnings EPS Misses Estimates as Stock Gains 23 FiEE Inc Q1 2023 Earnings EPS Misses Estimates by 41 Stock Slightly Down Lithium Argentina LAR Rebounds 137 Approaches Key Resistance at 1087 First Citizens BancShares Preferred FCNCN Steady Trading Near Midpoint of Range Eldorado Gold EGO Slips 11 as Gold Pressure Mounts Support Levels in Focus VivoPower VIVO Surges Over 10 as Momentum Builds Above Key Support Webull Warrants BULLW Slide 95 as Selling Pressure Intensifies Near Key Support Traders Shift Expectations Fed Rate Hike Now Priced in as Soon as December Following Inflation Surge WeRide Inc WRD Q1 2026 Earnings EPS Misses Estimates as Revenue Disappears Tejon Ranch TRC Holds Steady Near Support as Modest Gains Continue CRUS Q1 Fiscal 2026 Earnings Strong EPS Beat Amidst Revenue Uncertainty Investors Title Company ITIC Q4 2025 Earnings Strong EPS of 397 Amid Quiet Quarter MBINN Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Lower Precipio Inc PRPO Q2 2025 Earnings Unexpected Profitability Amid Revenue Challenges AEBI Q1 2026 Earnings EPS Misses Estimates Yet Stock Edges Higher Core Scientific CORZ Q1 2026 Earnings Massive EPS Miss Overshadowed by Positive Stock Reaction CG Oncology Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Continues Investment